AM‐induced microbiome alterations have been linked to dysregulation of metabolism, for example inducing low‐grade inflammation, decreasing insulin sensitivity and altering short‐chain fatty acid (SCFA) and bile acid metabolism,10 which are also present in obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.